AI summary · may contain errors
In 32 patients with HR+/HER2+ advanced breast cancer and measurable brain metastases, confirmed CNS-ORR reached 58.6% (95% CI 40.7–74.5) on palbociclib, fulvestrant, trastuzumab, and pyrotinib.
- Open access
Moving in JNCI: Journal of the National Cancer Institute, medRxiv, The Lancet Neurology, Neuro-Oncology, Annals of Neurology, bioRxiv, Clinical Cancer Research and JAMA Neurology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
In 32 patients with HR+/HER2+ advanced breast cancer and measurable brain metastases, confirmed CNS-ORR reached 58.6% (95% CI 40.7–74.5) on palbociclib, fulvestrant, trastuzumab, and pyrotinib.
AI summary · may contain errors
Plasma GFAP is consistently higher in females than males in two longitudinal cohorts (MERI N=584; ADNI), linking astrocytic reactivity to early AD biology.
AI summary · may contain errors
Abnormal Mini-Cog screening in 368 older adults (mean age 77.2) with advanced cancer initiating high-risk systemic therapy is linked to higher unplanned hospitalization (OR = 1.79).
AI summary · may contain errors
Delirium within 30 days of hospitalization in cognitively unimpaired adults in the Mayo Clinic Study of Aging is linked to higher incident MCI (aHR 3.67) and dementia (aHR 5.39).
AI summary · may contain errors
A harmonized LASI-DAD Wave 1 logistic regression model classified clinically rated dementia in 2,528 Indian adults with ROC-AUC 0.953 and Brier score 0.037.
AI summary · may contain errors
Higher baseline plasma p-tau217 predicts cognitive impairment in a pooled multi-ethnic cohort, with APOE-ε4 carriers showing stronger risk and earlier timing per 1-SD increase.
AI summary · may contain errors
Spontaneous menopause in rigorously staged women (n=80; STRAW+10; ages 43–58) is linked to dysregulated inflammatory, synaptic, metabolic, and Alzheimer’s disease proteomic processes that track more strongly with hormones than age.
AI summary · may contain errors
In 152 adults with hematologic cancer-related fatigue, methylphenidate improved FACIT-F fatigue scores by 8.9 points versus 3.9 with placebo, with a 5.0-point between-group advantage.
AI summary · may contain errors
Mild amyloid burden in cognitively unimpaired participants—Centiloid 0.93 to 20—predicts higher long-term risk of cognitive impairment, with separation emerging about 10 years post-baseline.
AI summary · may contain errors
Anti-amyloid monoclonal antibodies are clinically meaningful in symptomatic Alzheimer’s disease, and prevention trials are testing them in cognitively unimpaired people with biomarker evidence of AD neuropathological change (ADNC).
AI summary · may contain errors
MTD remote self-administered digital cognitive screening discriminated cognitively unimpaired from MCI/mild dementia with AUC=.89 (95% CI=.87–.92) in 2,131 CU and 118 impaired participants.
Journals this month
Topics moving, week to 17 Nov 2026
By field